The aim of the study is to evaluate the usability of the system and its accordance with the users' needs. This evaluation will consider the effectiveness and the efficiency of the system, as well as stroke survivors' satisfaction. The effectiveness and the efficiency of the system will be measured by: * The relationship between the control of stroke survivors' daily activities and their risk of having a secondary stroke, * The decrease of the need for caregivers, * And consequently an improvement in stroke survivors' self-management.
The aim of the study is to evaluate the usability of the system and its accordance with the users' needs. This evaluation will consider the effectiveness and the efficiency of the system, as well as stroke survivors' satisfaction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
40
The controls will get a conventional treatment from the acute to the chronic phase of stroke and the cases will get a conventional treatment till the end of the subacute phase. However, in the chronic period they will use the developed STARR App and DSS, as well as commercial wearables.
Hospital Universitario Cruces
Barakaldo, Bizkaia, Spain
RECRUITINGSystem Usability Scale
The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. Developers work to create systems that are easy and straight-forward for people to use. Terms such as "user friendly" and "easy-to-use" often indicate these characteristics, but the overall technical name for them is usability.
Time frame: 12 months
Age
This an outcome to evaluate the eligibility of the patient. Age variable will be in years.
Time frame: 12 months
Stroke date
This an outcome to evaluate the eligibility of the patient. This variable will be the patient stroke date.
Time frame: 12 months
Oxfordshire Community Stroke Project Classification
This an outcome to evaluate the eligibility of the patient. This variable will be useful in estimation of after stroke complications and prognostication.
Time frame: 12 months
Modified Barthel Index
This an outcome to evaluate the eligibility of the patient. This variable will assessing self care and mobility activities of daily living of the patient.
Time frame: 12 months
Mississippi Aphasia Screening Test
This an outcome to evaluate the eligibility of the patient. This variable will to be used to detect changes in language abilities over time of the patient.
Time frame: 12 months
Montreal Cognitive Assessment
This an outcome to evaluate the eligibility of the patient. This variable will be collected for detecting cognitive impairment of the patient.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 months
Gijon's social-familial evaluation Scale
Assess the social and family situation of people living in the home. Detect risk situations and social problems. There are no subscales. It has a global score. Score between 0-20 points, indicating higher score worse social situation.
Time frame: 12 months
Charlson Comorbidity Index
This an outcome to evaluate the eligibility of the patient.
Time frame: 12 months
Gender
This is a socio demographic outcome. This outcome will be collected as Male or Female.
Time frame: 12 months
Ethnic group
This is a socio demographic outcome.
Time frame: 12 months
Deprivation index
This is a socio demographic outcome.
Time frame: 12 months
Hand dominance
This is a socio demographic outcome. This outcome will be collected as right-handed and left-handed.
Time frame: 12 months
Education level
This is a socio demographic outcome.
Time frame: 12 months
Type of profession
This is a socio demographic outcome.
Time frame: 12 months
Hobbies
This is a socio demographic outcome.
Time frame: 12 months
Medical Research Council Scale
Scale for testing muscle strength in palsy. There are no subscales. It measures from Grade 0 (No contraction) to Grade 5 (Normal strength).
Time frame: 12 months
MAST Test
This is a neurological physical examination.
Time frame: 12 months
MoCA Test
This is a neurological physical examination.
Time frame: 12 months
Functional Ambulation Categories
This is a neurological physical examination.
Time frame: 12 months
10 Meters Walking Test
This is a neurological physical examination. The variable will collected in m/sg.
Time frame: 12 months
6 Minutes Walking Test
This is a neurological physical examination. The variable will collected in metres.
Time frame: 12 months
Berg Balance Scale
This is a neurological physical examination.
Time frame: 12 months
Frenchay Arm Test
This is a neurological physical examination.
Time frame: 12 months
Asworth Modified Scale
Scale for testing muscle spasticity. It rates severity of tone. There are no subscales. It measures from Grade 0 (No increase in muscle tone) to Grade 4 (Affected part(s) rigid in flexion or extension).
Time frame: 12 months
Fatigue Severity Scale
To measure the fatigue caused by a number of chronic medical conditions. There are no subscales. It has a global score. The FSS questionnaire contains nine statements. A low value (e.g., 1) indicates strong disagreement with the statement, whereas a high value (e.g., 7) indicates strong agreement. The total mean score is 7 points. FSS mean score \> 4 indicates severe fatigue.
Time frame: 12 months
Line Bisection Test
This is a neurological physical examination.
Time frame: 12 months
Disphagia
This is a neurological physical examination.
Time frame: 12 months
Campimetry
This is a neurological physical examination.
Time frame: 12 months
Analogic Visual Scale
This is a neurological physical examination.
Time frame: 12 months
Analgesic Treatments
This is a neurological physical examination.
Time frame: 12 months
Golberg Scale
This is a cardiovascular risk factor. To messure depression and anxiety.
Time frame: 12 months
Weight
This is a cardiovascular risk factor. In kg
Time frame: 12 months
Height
This is a cardiovascular risk factor. In meter
Time frame: 12 months
BMI
This is a cardiovascular risk factor.
Time frame: 12 months
Waist Size
This is a cardiovascular risk factor.
Time frame: 12 months
Waist to Hip Ratio
This is a cardiovascular risk factor.
Time frame: 12 months
Blood Pressure
This is a cardiovascular risk factor. In mmHg
Time frame: 12 months
Heart Rate
This is a cardiovascular risk factor.
Time frame: 12 months
Glycaemia
This is a cardiovascular risk factor.
Time frame: 12 months
Health Literacy Test
This is for measure the health literacy of the patient.
Time frame: 12 months
Mediterranean Diet Assessment Test
This is for measure the life style of the patient.
Time frame: 12 months
Physical Activity
This is for measure the life style of the patient.
Time frame: 12 months
Toxic Consumption
This is for measure the life style of the patient.
Time frame: 12 months
Total Cholesterol
This is a blood test for measure the lipidic profile of the patient.
Time frame: 12 months
HDL
This is a blood test for measure the lipidic profile of the patient.
Time frame: 12 months
LDL
This is a blood test for measure the lipidic profile of the patient.
Time frame: 12 months
Proteins
This is a blood test of the patient.
Time frame: 12 months
Albumin
This is a blood test of the patient.
Time frame: 12 months
HbA1c
This is a blood test of the patient.
Time frame: 12 months
Apoprotein B
This is a blood test of the patient.
Time frame: 12 months
Apoportein A1
This is a blood test of the patient.
Time frame: 12 months
Lawton Index
This is to messure the activities of daily living of the patient.
Time frame: 12 months
SF-36
This is to messure the quality of life of the patient.
Time frame: 12 months
SIS
This is to messure the quality of life of the patient.
Time frame: 12 months
Stroke Self Management Questionary
This is to messure the self management satisfaction of the patient.
Time frame: 12 months
Stroke Management Questionary
This is to messure the self management satisfaction of the patient.
Time frame: 12 months
Satisfaction Questionary
This is to messure the self management satisfaction of the patient.
Time frame: 12 months
Post Stroke Checklist
This is to messure the adherence to the treatment of the patient.
Time frame: 12 months
Pharmacological Accountability
This is to messure the adherence to the treatment of the patient.
Time frame: 12 months
Non Pharmacological Accountability
This is to messure the adherence to the treatment of the patient.
Time frame: 12 months
Stroke Recurrences
This is to messure the complications of the patient.
Time frame: 12 months
Number of Readmissions
This is to messure the complications of the patient.
Time frame: 12 months